查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386358

破傷風類毒素疫苗市場報告：2030 年趨勢、預測與競爭分析

Tetanus Toxoid Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

破傷風類毒素疫苗趨勢與預測

預計到 2030 年，全球破傷風類毒素疫苗市場預計將達到 18.1 億美元，2024 年至 2030 年年複合成長率為 5.6%。市場的主要促進因素是破傷風疫苗接種需求的增加、政府加強破傷風疫苗接種推廣配合措施以及擴大新型破傷風類毒素疫苗的開發。破傷風類毒素疫苗在醫院/診所和政府市場的全球市場未來性廣闊。

破傷風類毒素疫苗市場洞察

Lucintel 預測，由於政府配合措施根除白喉、破傷風和百日咳，預計白喉、破傷風和百日咳在預測期內將出現最高成長。

由於其完善的醫療保健系統，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球破傷風類毒素疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球破傷風類毒素疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球破傷風類毒素疫苗市場（按類型）
    • 單價破傷風類毒素
    • 破傷風白喉
    • 白喉、破傷風、百日咳
    • 其他
  • 全球破傷風類毒素疫苗市場（依型態）
    • 四價
    • 五價
    • 六價
  • 全球破傷風類毒素疫苗市場（依最終用途）
    • 醫院和診所
    • 政府機關
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球破傷風類毒素疫苗市場區域分佈
  • 北美破傷風類毒素疫苗市場
  • 歐洲破傷風類毒素疫苗市場
  • 亞太地區破傷風類毒素疫苗市場
  • 其他區域破傷風類毒素疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球破傷風類毒素疫苗市場成長機會（按類型）
    • 全球破傷風類毒素疫苗市場成長機會（按型態）
    • 全球破傷風類毒素疫苗市場成長機會（依最終用途）
    • 全球破傷風類毒素疫苗市場成長機會（按地區）
  • 全球破傷風類毒素疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球破傷風類毒素疫苗市場產能
    • 全球破傷風類毒素疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech
簡介目錄

Tetanus Toxoid Vaccine Trends and Forecast

The future of the global tetanus toxoid vaccine market looks promising with opportunities in the hospital & clinic and government organisation markets. The global tetanus toxoid vaccine market is expected to reach an estimated $1.81 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing demand for tetanus vaccination, increasing government initiatives to promote tetanus vaccination, and expanding development of new tetanus toxoid vaccines.

A more than 150-page report is developed to help in your business decisions.

Tetanus Toxoid Vaccine by Segment

The study includes a forecast for the global tetanus toxoid vaccine by type, form, end use, and region.

Tetanus Toxoid Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Tetanus Toxoid
  • Tetanus-Diphtheria
  • Diphtheria, Tetanus, and Pertussis
  • Others

Tetanus Toxoid Vaccine Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Quadrivalent
  • Pentavalent
  • Hexavalent

Tetanus Toxoid Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Government Organisations
  • Others

Tetanus Toxoid Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Tetanus Toxoid Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies tetanus toxoid vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the tetanus toxoid vaccine companies profiled in this report include-

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech

Tetanus Toxoid Vaccine Market Insights

Lucintel forecasts that diphtheria, tetanus, & pertussis is expected to witness highest growth over the forecast period due to increasing government initiatives for the eradication of these diseases.

North America is expected to witness highest growth over the forecast period due to presence of well-established healthcare systems in the region.

Features of the Global Tetanus Toxoid Vaccine Market

Market Size Estimates: Tetanus toxoid vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Tetanus toxoid vaccine market size by type, form, end use, and region in terms of value ($B).

Regional Analysis: Tetanus toxoid vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, forms, end uses, and regions for the tetanus toxoid vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the tetanus toxoid vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the tetanus toxoid vaccine market size?

Answer: The global tetanus toxoid vaccine market is expected to reach an estimated $1.81 billion by 2030.

Q.2 What is the growth forecast for tetanus toxoid vaccine market?

Answer: The global tetanus toxoid vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the tetanus toxoid vaccine market?

Answer: The major drivers for this market are increasing demand for tetanus vaccination, increasing government initiatives to promote tetanus vaccination, and expanding development of new tetanus toxoid vaccines.

Q4. What are the major segments for tetanus toxoid vaccine market?

Answer: The future of the tetanus toxoid vaccine market looks promising with opportunities in the hospital & clinic and government organisation markets.

Q5. Who are the key tetanus toxoid vaccine market companies?

Answer: Some of the key tetanus toxoid vaccine companies are as follows:

  • Merck
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Bharat Biotech

Q6. Which tetanus toxoid vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that diphtheria, tetanus, & pertussis is expected to witness highest growth over the forecast period due to increasing government initiatives for the eradication of these diseases.

Q7. In tetanus toxoid vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of well-established healthcare systems in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the tetanus toxoid vaccine market by type (monovalent tetanus toxoid, tetanus-diphtheria, diphtheria, tetanus, & pertussis, and others), form (quadrivalent, pentavalent, and hexavalent), end use (hospitals & clinics, government organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Tetanus Toxoid Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Tetanus Toxoid Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Tetanus Toxoid Vaccine Market by Type
    • 3.3.1: Monovalent Tetanus Toxoid
    • 3.3.2: Tetanus-Diphtheria
    • 3.3.3: Diphtheria, Tetanus, & Pertussis
    • 3.3.4: Others
  • 3.4: Global Tetanus Toxoid Vaccine Market by Form
    • 3.4.1: Quadrivalent
    • 3.4.2: Pentavalent
    • 3.4.3: Hexavalent
  • 3.5: Global Tetanus Toxoid Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Government Organisations
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Tetanus Toxoid Vaccine Market by Region
  • 4.2: North American Tetanus Toxoid Vaccine Market
    • 4.2.2: North American Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.3: European Tetanus Toxoid Vaccine Market
    • 4.3.1: European Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.3.2: European Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.4: APAC Tetanus Toxoid Vaccine Market
    • 4.4.1: APAC Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.4.2: APAC Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others
  • 4.5: ROW Tetanus Toxoid Vaccine Market
    • 4.5.1: ROW Tetanus Toxoid Vaccine Market by Type: Monovalent Tetanus Toxoid, Tetanus-Diphtheria, Diphtheria, Tetanus, & Pertussis, and Others
    • 4.5.2: ROW Tetanus Toxoid Vaccine Market by End Use: Hospitals & Clinics, Government Organisations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Form
    • 6.1.3: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Tetanus Toxoid Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Tetanus Toxoid Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Tetanus Toxoid Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Tetanus Toxoid Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: GlaxoSmithKline
  • 7.3: Sanofi
  • 7.4: Pfizer
  • 7.5: Bharat Biotech